List of Excipients in API mirdametinib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mirdametinib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | AMMONIA | 2032-02-11 |
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | BUTYL ALCOHOL | 2032-02-11 |
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | CELLULOSE, MICROCRYSTALLINE | 2032-02-11 |
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | CROSCARMELLOSE SODIUM | 2032-02-11 |
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | DEHYDRATED ALCOHOL | 2032-02-11 |
| SpringWorks Therapeutics Inc | MIRDAMETINIB | mirdametinib | 82448-130 | FD&C BLUE NO. 1 | 2032-02-11 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for mirdametinib
Excipient focus: AMMONIA
mirdametinib drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
mirdametinib drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mirdametinib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
mirdametinib drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DEHYDRATED ALCOHOL
mirdametinib drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
mirdametinib drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
mirdametinib drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
mirdametinib drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
mirdametinib drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mirdametinib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
mirdametinib drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
mirdametinib drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
mirdametinib drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
mirdametinib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
mirdametinib drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| SpringWorks Therapeutics Inc | mirdametinib | 82448-130 |
| >Company | >Ingredient | >NDC |
mirdametinib drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch